MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment

Kentaro Inamura1, Yuichi Ishikawa2

  • 1Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan. kentaro.inamura@jfcr.or.jp.

Insights

MicroRNAs play a key role in lung cancer development and progression. These small molecules show promise as biomarkers for early diagnosis and as novel therapeutic targets for lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Lung cancer remains a leading cause of cancer mortality globally.
  • Current diagnostic tools and therapies for lung cancer have limitations, contributing to poor patient outcomes.
  • MicroRNAs (miRNAs), small non-coding RNAs, regulate gene expression and are implicated in various biological processes, including cancer.

Purpose of the Study:

  • To review the role of microRNAs in lung cancer development and progression.
  • To explore the potential of microRNAs as biomarkers for early lung cancer diagnosis.
  • To discuss microRNAs as potential therapeutic targets for lung cancer treatment.

Main Methods:

  • Literature review of studies on microRNAs in lung cancer.
  • Analysis of research on microRNA expression profiles and their correlation with lung cancer subtypes and prognosis.
  • Investigation of microRNAs' presence in body fluids for biomarker potential.

Main Results:

  • MicroRNA profiles can classify lung cancer subtypes.
  • Specific microRNA expression signatures differentiate between favorable and unfavorable prognoses.
  • Circulating microRNAs in body fluids suggest potential as diagnostic and prognostic biomarkers.

Conclusions:

  • MicroRNAs are significantly involved in the development and progression of lung cancer.
  • MicroRNAs hold promise as novel biomarkers for early detection and prognosis prediction in lung cancer.
  • MicroRNAs represent potential novel tools for targeted lung cancer therapies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K